Zobrazeno 1 - 10
of 128
pro vyhledávání: '"P F, Halloran"'
Autor:
Ondrej Viklicky, MD, PhD, Petra Hruba, PhD, Marek Novotny, MD, Martin Kment, MD, Matej Roder, PhD, Philip F. Halloran, MD, PhD, Georg A. Böhmig, MD
Publikováno v:
Transplantation Direct, Vol 10, Iss 8, p e1685 (2024)
Externí odkaz:
https://doaj.org/article/46b67c6ad2554e899895c377868ff1b8
Autor:
A. Zajacova, M. Mackova, K. Halloran, P. Gauthier, J. Balko, M. Guney, D. Rakita, M. Svorcova, J. Kolarik, J. Vachtenheim, J. Pozniak, J. Simonek, L. Fila, R. Lischke, P. F. Halloran, J. Havlin
Publikováno v:
Transplant International, Vol 37 (2024)
Histologic evaluation of allograft biopsies after lung transplantation has several limitations, suggesting that molecular assessment using tissue transcriptomics could improve biopsy interpretation. This single-center, retrospective cohort study eval
Externí odkaz:
https://doaj.org/article/e86b76fc8b5e40a19fa4f54a47224216
Autor:
Matthias Diebold, Evan A. Farkash, Jenna Barnes, Heinz Regele, Nicolas Kozakowski, Martina Schatzl, Katharina A. Mayer, Susanne Haindl, Hannes Vietzen, Luis G. Hidalgo, Philip F. Halloran, Farsad Eskandary, Georg A. Böhmig
Publikováno v:
Transplant International, Vol 37 (2024)
Transcript analyses highlight an important contribution of natural killer (NK) cells to microvascular inflammation (MVI) in antibody-mediated rejection (ABMR), but only few immunohistologic studies have quantified their spatial distribution within gr
Externí odkaz:
https://doaj.org/article/4a4b715a60db4143affa7743c8c87e4b
Autor:
Carsten T. Herz, Matthias Diebold, Alexander Kainz, Katharina A. Mayer, Konstantin Doberer, Nicolas Kozakowski, Philip F. Halloran, Georg A. Böhmig
Publikováno v:
Transplant International, Vol 36 (2023)
Current knowledge about the factors correlating with functional decline and subsequent failure of kidney allografts in antibody-mediated rejection (ABMR) is limited. We conducted a cohort study involving 75 renal allograft recipients diagnosed with l
Externí odkaz:
https://doaj.org/article/9d480fdc2ad54512a63093ab89d488d3
Autor:
Katharina A. Mayer, Klemens Budde, Philip F. Halloran, Konstantin Doberer, Lionel Rostaing, Farsad Eskandary, Anna Christamentl, Markus Wahrmann, Heinz Regele, Sabine Schranz, Sarah Ely, Christa Firbas, Christian Schörgenhofer, Alexander Kainz, Alexandre Loupy, Stefan Härtle, Rainer Boxhammer, Bernd Jilma, Georg A. Böhmig
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-15 (2022)
Abstract Background Antibody-mediated rejection (ABMR) is a cardinal cause of renal allograft loss. This rejection type, which may occur at any time after transplantation, commonly presents as a continuum of microvascular inflammation (MVI) culminati
Externí odkaz:
https://doaj.org/article/4f8aa02fcc984a15b6ec9bd5b10aa1db
Autor:
Katharina A. Mayer, MD, Konstantin Doberer, MD, Philip F. Halloran, MD, PhD, Klemens Budde, MD, Susanne Haindl, BSc, Jakob Mühlbacher, MD, PhD, Farsad Eskandary, MD, PhD, Thierry Viard, PhD, Silvia Casas, PhD, Bernd Jilma, MD, Georg A. Böhmig, MD
Publikováno v:
Transplantation Direct, Vol 8, Iss 12, p e1406 (2022)
Background. Targeting interleukin-6 (IL-6) was shown to counteract donor-specific antibody production and antibody-mediated rejection (AMR) activity. It is not known whether, or to what extent, IL-6 antagonism modulates biomarkers indicative of tissu
Externí odkaz:
https://doaj.org/article/1b4f38eab9a245a0b1242fec75aaff19
Autor:
Petra Hruba, Katellyn Madill-Thomsen, Martina Mackova, Jiri Klema, Jana Maluskova, Ludek Voska, Alena Parikova, Janka Slatinska, Philip F. Halloran, Ondrej Viklicky
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Abstract The Banff 2019 kidney allograft pathology update excluded isolated tubulitis without interstitial inflammation (ISO-T) from the category of borderline (suspicious) for acute T cell-mediated rejection due to its proposed benign clinical outco
Externí odkaz:
https://doaj.org/article/aa45873e82da4b13837a9070dabff930
Autor:
Philip F. Halloran, Georg A. Böhmig, Jonathan Bromberg, Gunilla Einecke, Farsad A. Eskandary, Gaurav Gupta, Marek Myslak, Ondrej Viklicky, Agnieszka Perkowska-Ptasinska, Katelynn S. Madill-Thomsen, The INTERCOMEX Investigators
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
All transplanted kidneys are subjected to some degree of injury as a result of the donation-implantation process and various post-transplant stresses such as rejection. Because transplants are frequently biopsied, they present an opportunity to explo
Externí odkaz:
https://doaj.org/article/b8c79229ec6143be85d020448c4e2df2
Deletion of the Natural Killer Cell Receptor NKG2C Encoding KLR2C Gene and Kidney Transplant Outcome
Autor:
Hannes Vietzen, Bernd Döhler, Thuong Hien Tran, Caner Süsal, Philip F. Halloran, Farsad Eskandary, Carsten T. Herz, Katharina A. Mayer, Nicolas Kozakowski, Markus Wahrmann, Sarah Ely, Susanne Haindl, Elisabeth Puchhammer-Stöckl, Georg A. Böhmig
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Natural killer (NK) cells may contribute to antibody-mediated rejection (ABMR) of renal allografts. The role of distinct NK cell subsets in this specific context, such as NK cells expressing the activating receptor NKG2C, is unknown. Our aim was to i
Externí odkaz:
https://doaj.org/article/7f1da3a674a440bb928dea63699ae42a
Autor:
Farsad Eskandary, Michael Dürr, Klemens Budde, Konstantin Doberer, Roman Reindl-Schwaighofer, Johannes Waiser, Markus Wahrmann, Heinz Regele, Andreas Spittler, Nils Lachmann, Christa Firbas, Jakob Mühlbacher, Gregor Bond, Philipp F. Halloran, Edward Chong, Bernd Jilma, Georg A. Böhmig
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-13 (2019)
Abstract Background Late antibody-mediated rejection (ABMR) triggered by donor-specific antibodies (DSA) is a cardinal cause of kidney allograft dysfunction and loss. Diagnostic criteria for this rejection type are well established, but effective tre
Externí odkaz:
https://doaj.org/article/f9f9861b28ea4b8fb1fe6e6eb9d5070c